B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: Results from the AtheroGene study

Journal of the American College of Cardiology

Volumn 47, Issue 3, 2006, Pages 552-558

  Schnabel, Renate ^a   Lubos, Edith ^a   Rupprecht, Hans J ^a   Espinola Klein, Christine ^a   Bickel, Christoph ^c   Lackner, Karl J ^a   Cambien, François ^b   Tiret, Laurence ^b   Münzel, Thomas ^a   Blankenberg, Stefan ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c BUNDESWEHRZENTRALKRANKENHAUS KOBLENZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STABLE ANGINA PECTORIS;

EID: 31644431678     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.09.039     Document Type: Article

References (24)

1. J.A. de Lemos, D.K. McGuire, M.H. Drazner B-type natriuretic peptide in cardiovascular disease Lancet 362 2003 316 322
2. M. Toth, K.H. Vuorinen, O. Vuolteenaho Hypoxia stimulates release of ANP and BNP from perfused rat ventricular myocardium Am J Physiol 266 1994 H1572 H1580
3. S.P. D'Souza, M. Davis, G.F. Baxter Autocrine and paracrine actions of natriuretic peptides in the heart Pharmacol Ther 101 2004 113 129
4. J.P. Goetze, C. Christoffersen, M. Perko Increased cardiac BNP expression associated with myocardial ischemia Faseb J 17 2003 1105 1107
5. J.A. de Lemos, D.A. Morrow, J.H. Bentley The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes N Engl J Med 345 2001 1014 1021
6. T. Omland, J.A. de Lemos, D.A. Morrow Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes Am J Cardiol 89 2002 463 465
7. T. Jernberg, M. Stridsberg, P. Venge, B. Lindahl N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation J Am Coll Cardiol 40 2002 437 445
8. S.K. James, B. Lindahl, A. Siegbahn N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease a Global Utilization of Strategies to Open Occluded Arteries (GUSTO)-IV substudy Circulation 108 2003 275 281
9. R. Schnabel, H.J. Rupprecht, K.J. Lackner Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease results from the AtheroGene study Eur Heart J 26 2005 241 249
10. C. Kragelund, B. Gronning, L. Kober, P. Hildebrandt, R. Steffensen N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease N Engl J Med 352 2005 666 675
11. A.M. Richards, R. Doughty, M.G. Nicholls Australia-New Zealand Heart Failure Group Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction J Am Coll Cardiol 37 2001 1781 1787
12. A.M. Richards, R. Doughty, M.G. Nicholls Australia-New Zealand Heart Failure Group Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction Circulation 99 1999 786 792
13. T. Omland, A.M. Richards, R. Wergeland, H. Vik-Mo B-type natriuretic peptide and long-term survival in patients with stable coronary artery disease Am J Cardiol 95 2005 24 28
14. S. Blankenberg, H.J. Rupprecht, C. Bickel Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease N Engl J Med 349 2003 1605 1613
15. H.T. Dodge, H. Sandler, W.A. Baxley, R.R. Hawley Usefulness and limitations of radiographic methods for determining left ventricular volume Am J Cardiol 18 1966 10 24
16. L. Cabanes, B. Richaud-Thiriez, Y. Fulla Brain natriuretic peptide blood levels in the differential diagnosis of dyspnea Chest 120 2001 2047 2050
17. S. Talwar, I.B. Squire, J.E. Davies, D.B. Barnett, L.L. Ng Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population Eur Heart J 20 1999 1736 1744
18. K. Marumoto, M. Hamada, K. Hiwada Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris Clin Sci (Lond) 88 1995 551 556
19. T.J. Wang, M.G. Larson, D. Levy Plasma natriuretic peptide levels and the risk of cardiovascular events and death N Engl J Med 350 2004 655 663
20. A.S. Maisel, P. Krishnaswamy, R.M. Nowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
21. N.S. Anavekar, J.J. McMurray, E.J. Velazquez Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction N Engl J Med 351 2004 1285 1295
22. M.W. Yerkey, S.J. Kernis, B.A. Franklin, K.R. Sandberg, P.A. McCullough Renal dysfunction and acceleration of coronary disease Heart 90 2004 961 966
23. D.O. McGregor, R.W. Troughton, C. Frampton Hypotensive and natriuretic actions of adrenomedullin in subjects with chronic renal impairment Hypertension 37 2001 1279 1284
24. D.B. Mark, G.M. Felker B-type natriuretic peptide - a biomarker for all seasons? N Engl J Med 350 2004 718 720